Near fatal hemorrhage in traumatic bilateral leg amputation with coagulopathy, acidosis, and hypothermia and salvage therapy with recombinant factor VIIa

Journal of Trauma - Injury, Infection and Critical Care

Volumn 63, Issue 1, 2007, Pages

  Korte, Wolfgang C ^a,b   Moor, Sabine ^a  

^a KANTONSSPITAL   (Switzerland)

^b Institute for Clinical Chemistry and Hematology   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ACIDOSIS; ADOLESCENT; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD GAS ANALYSIS; BLOOD TRANSFUSION; CASE REPORT; DISEASE COURSE; DRUG EFFECT; HEMOGLOBIN DETERMINATION; HUMAN; HYPOTENSION; HYPOTHERMIA; LEG AMPUTATION; LEG INJURY; MALE; PRIORITY JOURNAL; SALVAGE THERAPY; TACHYCARDIA; THROMBOCYTE COUNT; TRAFFIC ACCIDENT; TREATMENT RESPONSE;

ACCIDENTS; ACIDOSIS; ADOLESCENT; AMPUTATION, TRAUMATIC; BLOOD COAGULATION DISORDERS; BLOOD GAS ANALYSIS; BLOOD VOLUME; FACTOR VII; HEMORRHAGE; HEMOSTASIS, SURGICAL; HUMANS; HYPOTHERMIA; LEG INJURIES; MALE; RAILROADS; RECOMBINANT PROTEINS; SALVAGE THERAPY; TREATMENT FAILURE;

EID: 34447320243     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000246956.72328.6c     Document Type: Article

References (26)

1. Asensio JA, McDuffie L, Petrone P, et al. Reliable variables in the exsanguinated patient which indicate damage control and predict outcome. Am J Surg. 2001;182:743-751.
2. Vaslef SN, Knudsen NW, Neligan PJ, et al. Massive transfusion exceeding 50 units of blood products in trauma patients. J Trauma. 2002;53:291-295; discussion 295-296.
3. Rotondo MF, Zonies DH. The damage control sequence and underlying logic. Surg Clin North Am. 1997;77:761-777.
4. Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma. 2001;51:431-438; discussion 438-439.
5. Meng ZH, Wolberg AS, Monroe DM, 3rd, et al. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma. 2003;55:886-891.
6. Blazar PE, Dormans JP, Born CT. Train injuries in children. J Orthop Trauma. 1997;11:126-129.
7. Goldberg BA, Mootha RK, Lindsey RW. Train accidents involving pedestrians, motor vehicles, and motorcycles. Am J Orthop. 1998;27:315-320.
8. Bick RL, Arun B, Frenkel EP. Disseminated intravascular coagulation. Clinical and pathophysiological mechanisms and manifestations. Haemostasis. 1999;29:111-134.
9. Taylor FB Jr, Toh CH, Hoots WK, et al. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327-1330.
10. Zupancic Salek S, Sokolic V, Viskovic T, et al. Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome. Acta Haematol. 2002;108:162-163.
11. Kastrup M, von Heymann C, Hotz H, et al. Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg. 2002;74:910-912.
12. Gerlach R, Marquardt G, Wissing H, et al. Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. Case report. J Neurosurg. 2002;96:946-948.
13. Moscardo F, Perez F, de la Rubia J, et al. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol. 2001;114:174-176.
14. Hendriks HG, van der Maaten JM, de Wolf J, et al. An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg. 2001;93:287-289.
15. White B, O'Connor H, Smith OP. Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency. Blood Coagul Fibrinolysis. 2000;11:155-157.
16. Vlot AJ, Ton E, Mackaay AJ, et al. Treatment of a severely bleeding patient without preexisting coagulopathy with activated recombinant factor VII. Am J Med. 2000;108:421-423.
17. Aldouri M. The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients. Pathophysiol Haemost Thromb. 2002;32(Suppl 1):41-46.
18. Martinowitz U, Kenet G, Lubetski A, et al. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anaesth. 2002;49:S15-S20.
19. Martinowitz U, Holcomb JB, Pusateri AE, et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma. 2001;50:721-729.
20. Velmahos GC, Chan L, Chan M, et al. Is there a limit to massive blood transfusion after severe trauma? Arch Surg. 1998;133:947-952.
21. van't Veer C, Mann KG. The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders. Semin Thromb Hemost. 2000;26:367-372.
22. Monroe DM, Hoffman M, Allen GA, et al. The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia. Semin Thromb Hemost. 2000;26:373-377.
23. Galan AM, Tonda R, Pino M, et al. Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders. Transfusion. 2003;43:885-892.
24. Van Thiel DH, Anantharaju A, Mindikoglu AL, et al. Modulation of endothelial cell inflammatory integrins and stress markers with rhfactor VIIa in patients with advanced chronic hepatitis C. J Viral Hepat. 2003;10:310-317.
25. Gando S, Kameue T, Matsuda N, et al. Combined activation of coagulation and inflammation has an important role in multiple organ dysfunction and poor outcome after severe trauma. Thromb Haemost. 2002;88:943-949.
26. Lisman T, Moschatsis S, Adelmeijer J, et al. Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation. Blood. 2003;101:1864-1870.